144 related articles for article (PubMed ID: 1898253)
1. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
Sparks DL; Markesbery WR
Arch Neurol; 1991 Aug; 48(8):796-9. PubMed ID: 1898253
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual.
Sparks DL; Danner FW; Davis DG; Hackney C; Landers T; Coyne CM
J Neuropathol Exp Neurol; 1994 Jan; 53(1):37-42. PubMed ID: 8301318
[TBL] [Abstract][Full Text] [Related]
3. Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat.
Gasbarri A; Sulli A; Pacitti C; McGaugh JL
Neuroscience; 1999; 91(3):1129-42. PubMed ID: 10391489
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical observations in a case of Pick's disease.
Yates CM; Simpson J; Maloney AF; Gordon A
J Neurol Sci; 1980 Nov; 48(2):257-63. PubMed ID: 7431041
[TBL] [Abstract][Full Text] [Related]
5. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
6. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
[TBL] [Abstract][Full Text] [Related]
7. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
[TBL] [Abstract][Full Text] [Related]
8. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
Arai H; Iizuka R
Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
[No Abstract] [Full Text] [Related]
9. Dysfunction of the brain cholinergic system during aging and after lesions of the nucleus basalis of Meynert.
Pepeu G; Marconcini Pepeu I
J Neural Transm Suppl; 1994; 44():189-94. PubMed ID: 7897390
[TBL] [Abstract][Full Text] [Related]
10. Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert.
Uhl GR; Hilt DC; Hedreen JC; Whitehouse PJ; Price DL
Neurology; 1983 Nov; 33(11):1470-3. PubMed ID: 6685239
[TBL] [Abstract][Full Text] [Related]
11. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
[TBL] [Abstract][Full Text] [Related]
12. Lack of cholinergic deficit in the neocortex in Pick's disease.
Wood PL; Nair NP; Etienne P; Lal S; Gauthier S; Robitaille Y; Bird ED; Palo J; Haltia M; Paetau A
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):725-7. PubMed ID: 6141615
[TBL] [Abstract][Full Text] [Related]
13. Sudden infant death syndrome: altered aminergic-cholinergic synaptic markers in hypothalamus.
Sparks DL; Hunsaker JC
J Child Neurol; 1991 Oct; 6(4):335-9. PubMed ID: 1719064
[TBL] [Abstract][Full Text] [Related]
14. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.
Ichimiya Y; Arai H; Kosaka K; Iizuka R
Acta Neuropathol; 1986; 70(2):112-6. PubMed ID: 3739621
[TBL] [Abstract][Full Text] [Related]
15. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
[TBL] [Abstract][Full Text] [Related]
16. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor promotes survival of cultured magnocellular cholinergic neurons from nucleus basalis of Meynert in postnatal rats.
Hatanaka H; Nihonmatsu I; Tsukui H
Neurosci Lett; 1988 Jul; 90(1-2):63-8. PubMed ID: 2842704
[TBL] [Abstract][Full Text] [Related]
18. The nucleus basalis of Meynert.
Ezrin-Waters C; Resch L
Can J Neurol Sci; 1986 Feb; 13(1):8-14. PubMed ID: 2937514
[TBL] [Abstract][Full Text] [Related]
19. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Bowen DM; Allen SJ; Benton JS; Goodhardt MJ; Haan EA; Palmer AM; Sims NR; Smith CC; Spillane JA; Esiri MM; Neary D; Snowdon JS; Wilcock GK; Davison AN
J Neurochem; 1983 Jul; 41(1):266-72. PubMed ID: 6306169
[TBL] [Abstract][Full Text] [Related]
20. The nucleus basalis of Meynert in neurological dementing disease: a review.
Chozick B
Int J Neurosci; 1987 Nov; 37(1-2):31-48. PubMed ID: 2960633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
